Connected Drug Delivery Devices Market , by Type (Injectable Devices, Inhalation Devices, and Others), by Technology (NFC, Bluetooth, Others), by End-User (Homecare settings and Hospitals) Regional Analysis (North America, Europe, Asia Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027
- RES4072077
- 180 Pages
- August 2020
- Healthcare
Connected drug delivery is an emerging technology that helps in addressing people’s health issues regarding disease management protocols, medications, and treatments.
Impact Analysis of COVID-19 on Connected Drug Delivery Devices Market:
The unexpected situation created by COVID-19 across the countries has led to the lockdown of businesses for an uncertain period of time. The processes of industries like product manufacturing, inventory and logistics management are disrupted mainly because of the pandemic spread, which will eventually create a massive impact on the global industry. On the other hand, the COVID-19 outbreak may create a considerable impact on the global market for connected drug delivery devices. Notable industry players operating in the connected drug delivery technologies are implementing effective strategies to support the society, along with to strengthen their position worldwide. For example, in January 2020, Aptar Pharma, the U.S. based drug delivery systems company, teamed up with Lupin, leading multinational pharma venture to release ADHERO, connected drug delivery device for asthma and COPD (chronic obstructive pulmonary disease) patients in India. The device mainly helps to enhance the patient’s adherence to the prescribed therapy. These strategy implementations by market players amid the COVID-19 chaos may offer extensive opportunities for the global connected drug delivery devices market.
The growing prevalence of chronic illnesses such as diabetes, COPD (chronic obstructive pulmonary disease), cancer, and asthma worldwide is expected to increase the demand for drugs and advanced medical devices, which will ultimately accelerate the global connected drug delivery market, during the forecast timeframe. Moreover, multiple ventures across the world, such as BD., LOG pharma, and AptarGroup Inc, are coming forward with the effective strategies to gain the trust of society. For example, in November 2019, LOG pharma, a leading company in the healthcare sector, has made an announcement to launch IoT-enabled ‘ActiveGuard’ smart device. This device is mainly designed to resolve the problem of a lack of patient adherence to prescribed medicines. These initiatives and technological upgradations may lead to bolster the global connected drug delivery devices market growth, in the analysis period.
The higher costs associated with connected drug delivery devices coupled with a lack of awareness among the people about the recent innovations may create a negative impact on the global industry, throughout the review period.
The integration of cutting-edge technologies in the connected drug delivery devices is expected to register significant revenue during the analysis timeframe. Market leaders involved in the global market are implementing the latest technologies to develop effective and cost-effective connected drug delivery devices. For example, in October 2018, Phillips-Medisize, a notable player in developing medical devices, has announced that they have released a ‘cloud-based data system’ especially for the drug delivery device manufacturers. These elements may lead to creating market opportunities for the global connected drug delivery devices market, in the future.
Based on the type the global market is mainly categorized into inhalation devices, injectable devices, and others. Injectable devices have a significant share and they are projected to generate a revenue of $652.2 million by 2027, increasing from $113.1 million in 2019. On the other hand, inhalation devices will have a rapid market and they are anticipated to generate a revenue of $467.1 million by 2027, rising from $76.3 million in 2019.
On the basis of technology, the global market for connected drug delivery devices is classified into Bluetooth, NFC, and others. The Bluetooth technology shall have substantial market share and it is projected to account for $733.0 million by 2027, with a rise from $122.8 million in 2019. However, the NFC technology will have exponential growth in the global industry and is anticipated to generate a revenue of $290.3 million, by 2027.
Depending on the end-user, the global connected drug delivery devices market is divided into hospitals and homecare settings. The hospital sub-segment will have a massive market share and is projected to generate a revenue of $805.8 million by 2027, surging from $141.6 million in 2019. Contrary to this, the homecare settings sub-segment will be the fastest-growing sub-segment and is predicted to register a revenue of $313.5 million by the end of 2027.
The connected drug delivery devices’ market for the Asia-Pacific region is projected to increase at a growth rate of 26.3% by registering revenue of $190.3 million by 2027. However, North America connected drug delivery devices market registered a revenue of $78.9 million in 2019 and it is estimated to reach upto $436.5 million by 2027.
The leading global connected drug delivery devices market players consist of BD, Adherium, propeller Health, Proteus Digital Health, F. Hoffmann-La Roche Ltd, AptarGroup Inc. West Pharmaceutical Services, Syncro Technology Corp., Cohero Health, Inc., and Ypsomed AG. The connected drug delivery devices market leaders are following strategies such as product innovation and their launching, capacity expansions, and strategic tie-ups.
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Type trends
2.3. Technology trends
2.4. End-User trends
3. Market Overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Pricing overview
3.8.1. By Type
3.8.2. By Technology
3.8.3. By End-User
3.9. Market value chain analysis
3.9.1. Stress point analysis
3.9.2. Raw material analysis
3.9.3. Manufacturing process
3.9.4. Distribution channel analysis
3.9.5. Operating vendors
3.9.5.1. Raw material suppliers
3.9.5.2. Product manufacturers
3.9.5.3. Product distributors
3.10. Strategic overview
4. Connected Drug Delivery Devices Market, by Type
4.1. Injectable Devices
4.1.1. Market size and forecast, by region, 2020-2027
4.1.2. Comparative market share analysis, 2020 & 2027
4.2. Inhalation Devices
4.2.1. Market size and forecast, by region, 2020-2027
4.2.2. Comparative market share analysis, 2020 & 2027
4.3. Others
4.3.1. Market size and forecast, by region, 2020-2027
4.3.2. Comparative market share analysis, 2020 & 2027
5. Connected Drug Delivery Devices Market, by Technology
5.1. NFC
5.1.1. Market size and forecast, by region, 2020-2027
5.1.2. Comparative market share analysis, 2020 & 2027
5.2. Bluetooth
5.2.1. Market size and forecast, by region, 2020-2027
5.2.2. Comparative market share analysis, 2020 & 2027
5.3. Others
5.3.1. Market size and forecast, by region, 2020-2027
5.3.2. Comparative market share analysis, 2020 & 2027
5.4. Connected drug delivery devices Market, by End-User
5.5. Hospital
5.5.1. Market size and forecast, by region, 2020-2027
5.5.2. Comparative market share analysis, 2020 & 2027
5.6. Homecare Settings
5.6.1. Market size and forecast, by region, 2020-2027
5.6.2. Comparative market share analysis, 2020 & 2027
6. Connected Drug Delivery Devices Market, by Region
6.1. North America
6.1.1. Market size and forecast, by type, 2020-2027
6.1.2. Market size and forecast, by technology, 2020-2027
6.1.3. Market size and forecast, by end-user, 2020-2027
6.1.4. Market size and forecast, by country, 2020-2027
6.1.5. Comparative market share analysis, 2020 & 2027
6.1.6. U.S.
6.1.6.1. Market size and forecast, by type, 2020-2027
6.1.6.2. Market size and forecast, by technology, 2020-2027
6.1.6.3. Market size and forecast, by end-user, 2020-2027
6.1.6.4. Comparative market share analysis, 2020 & 2027
6.1.7. Canada
6.1.7.1. Market size and forecast, by type, 2020-2027
6.1.7.2. Market size and forecast, by technology, 2020-2027
6.1.7.3. Market size and forecast, by end-user, 2020-2027
6.1.7.4. Comparative market share analysis, 2020 & 2027
6.1.8. Mexico
6.1.8.1. Market size and forecast, by type, 2020-2027
6.1.8.2. Market size and forecast, by technology, 2020-2027
6.1.8.3. Market size and forecast, by end-user, 2020-2027
6.1.8.4. Comparative market share analysis, 2020 & 2027
6.2. Europe
6.2.1. Market size and forecast, by type, 2020-2027
6.2.2. Market size and forecast, by technology, 2020-2027
6.2.3. Market size and forecast, by end-user, 2020-2027
6.2.4. Market size and forecast, by country, 2020-2027
6.2.5. Comparative market share analysis, 2020 & 2027
6.2.6. Germany
6.2.6.1. Market size and forecast, by type, 2020-2027
6.2.6.2. Market size and forecast, by technology, 2020-2027
6.2.6.3. Market size and forecast, by end-user, 2020-2027
6.2.6.4. Comparative market share analysis, 2020 & 2027
6.2.7. UK
6.2.7.1. Market size and forecast, by type, 2020-2027
6.2.7.2. Market size and forecast, by technology, 2020-2027
6.2.7.3. Market size and forecast, by end-user, 2020-2027
6.2.7.4. Comparative market share analysis, 2020 & 2027
6.2.8. France
6.2.8.1. Market size and forecast, by type, 2020-2027
6.2.8.2. Market size and forecast, by technology, 2020-2027
6.2.8.3. Market size and forecast, by end-user, 2020-2027
6.2.8.4. Comparative market share analysis, 2020 & 2027
6.2.9. Spain
6.2.9.1. Market size and forecast, by type, 2020-2027
6.2.9.2. Market size and forecast, by technology, 2020-2027
6.2.9.3. Market size and forecast, by end-user, 2020-2027
6.2.9.4. Comparative market share analysis, 2020 & 2027
6.2.10. Italy
6.2.10.1. Market size and forecast, by type, 2020-2027
6.2.10.2. Market size and forecast, by technology, 2020-2027
6.2.10.3. Market size and forecast, by end-user, 2020-2027
6.2.10.4. Comparative market share analysis, 2020 & 2027
6.2.11. Rest of Europe
6.2.11.1. Market size and forecast, by type, 2020-2027
6.2.11.2. Market size and forecast, by technology, 2020-2027
6.2.11.3. Market size and forecast, by end-user, 2020-2027
6.2.11.4. Comparative market share analysis, 2020 & 2027
6.3. Asia Pacific
6.3.1. Market size and forecast, by type, 2020-2027
6.3.2. Market size and forecast, by technology, 2020-2027
6.3.3. Market size and forecast, by end-user, 2020-2027
6.3.4. Market size and forecast, by country, 2020-2027
6.3.5. Comparative market share analysis, 2020 & 2027
6.3.6. China
6.3.6.1. Market size and forecast, by type, 2020-2027
6.3.6.2. Market size and forecast, by technology, 2020-2027
6.3.6.3. Market size and forecast, by end-user, 2020-2027
6.3.6.4. Comparative market share analysis, 2020 & 2027
6.3.7. India
6.3.7.1. Market size and forecast, by type, 2020-2027
6.3.7.2. Market size and forecast, by technology, 2020-2027
6.3.7.3. Market size and forecast, by end-user, 2020-2027
6.3.7.4. Comparative market share analysis, 2020 & 2027
6.3.8. Australia
6.3.8.1. Market size and forecast, by type, 2020-2027
6.3.8.2. Market size and forecast, by technology, 2020-2027
6.3.8.3. Market size and forecast, by end-user, 2020-2027
6.3.8.4. Comparative market share analysis, 2020 & 2027
6.3.9. Rest of Asia Pacific
6.3.9.1. Market size and forecast, by type, 2020-2027
6.3.9.2. Market size and forecast, by technology, 2020-2027
6.3.9.3. Market size and forecast, by end-user, 2020-2027
6.3.9.4. Comparative market share analysis, 2020 & 2027
6.4. LAMEA
6.4.1. Market size and forecast, by type, 2020-2027
6.4.2. Market size and forecast, by technology, 2020-2027
6.4.3. Market size and forecast, by end-user, 2020-2027
6.4.4. Market size and forecast, by country, 2020-2027
6.4.5. Comparative market share analysis, 2020 & 2027
6.4.6. Latin America
6.4.6.1. Market size and forecast, by type, 2020-2027
6.4.6.2. Market size and forecast, by technology, 2020-2027
6.4.6.3. Market size and forecast, by end-user, 2020-2027
6.4.6.4. Comparative market share analysis, 2020 & 2027
6.4.7. Middle East
6.4.7.1. Market size and forecast, by type, 2020-2027
6.4.7.2. Market size and forecast, by technology, 2020-2027
6.4.7.3. Market size and forecast, by end-user, 2020-2027
6.4.7.4. Comparative market share analysis, 2020 & 2027
6.4.8. Africa
6.4.8.1. Market size and forecast, by type, 2020-2027
6.4.8.2. Market size and forecast, by technology, 2020-2027
6.4.8.3. Market size and forecast, by end-user, 2020-2027
6.4.8.4. Comparative market share analysis, 2020 & 2027
7. Company Profiles
7.1. AptarGroup Inc.
7.1.1. Business overview
7.1.2. Financial performance
7.1.3. Product portfolio
7.1.4. Recent strategic moves & developments
7.1.5. SWOT analysis
7.2. Adherium
7.2.1. Business overview
7.2.2. Financial performance
7.2.3. Product portfolio
7.2.4. Recent strategic moves & developments
7.2.5. SWOT analysis
7.3. Proteus Digital Health
7.3.1. Business overview
7.3.2. Financial performance
7.3.3. Product portfolio
7.3.4. Recent strategic moves & developments
7.3.5. SWOT analysis
7.4. BD
7.4.1. Business overview
7.4.2. Financial performance
7.4.3. Product portfolio
7.4.4. Recent strategic moves & developments
7.4.5. SWOT analysis
7.5. F. Hoffmann-La Roche Ltd
7.5.1. Business overview
7.5.2. Financial performance
7.5.3. Product portfolio
7.5.4. Recent strategic moves & developments
7.5.5. SWOT analysis
7.6. propeller Health
7.6.1. Business overview
7.6.2. Financial performance
7.6.3. Product portfolio
7.6.4. Recent strategic moves & developments
7.6.5. SWOT analysis
7.7. Cohero Health, Inc.
7.7.1. Business overview
7.7.2. Financial performance
7.7.3. Product portfolio
7.7.4. Recent strategic moves & developments
7.7.5. SWOT analysis
7.8. Ypsomed AG
7.8.1. Business overview
7.8.2. Financial performance
7.8.3. Product portfolio
7.8.4. Recent strategic moves & developments
7.8.5. SWOT analysis
7.9. Syncro Technology Corp.
7.9.1. Business overview
7.9.2. Financial performance
7.9.3. Product portfolio
7.9.4. Recent strategic moves & developments
7.9.5. SWOT analysis
7.10. West Pharmaceutical Services
7.10.1. Business overview
7.10.2. Financial performance
7.10.3. Product portfolio
7.10.4. Recent strategic moves & developments
7.10.5. SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
